For the first time in its 58-year history, Medicare, the public health insurance program for seniors, will have the power to ask for price cuts from drugmakers thanks to the Inflation Reduction Act passed last year.

Congress is debating a Democratic proposal, H.R.3, that would allow the federal government to negotiate prescription drug prices in an effort to lower costs.

The new price -- starting Jan. 1 -- will be about $80 per vial and comparable to how much a vial of Lilly's brand name Humalog insulin cost in 2008.

After a report criticized Eli Lilly and Co. for not doing enough to make affordable insulin available, the company launched a campaign Thursday to raise awareness of their discount options.

Indiana lawmakers heard from drug makers, consumers, doctors and industry experts about some of the driving factors of drug pricing.

The group delivered a call for Young to sign on as a co-sponsor of the Prescription Drug Pricing Reduction Act moving through Congress.

Indiana legislators explored high drug prices this past session and will tackle the issue this summer again.

The Indianapolis drugmaker has begun selling its own generic version of Humalog U-100 under the chemical name insulin lispro. It will cost $137.35 per vial, or $265.20 for a package of five KwikPens.

One of the issues will be e-cigarette and CBD oil taxes. Thats something lawmakers couldnt agree on in the 2019 session.

The House Public Health Committee passed the bill, moving it to the full House.